|
Secondary prevention
Citations 451-460 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Clinician Update
Oral Anticoagulation for Acute Coronary Syndromes
- Marc A. Brouwer and Freek W.A. Verheugt
Circulation 2002;105:1270-1274, doi:10.1161/hc1102.105594
[Full text]
- Correspondence
Immunopathogenesis of Atherosclerosis • Response
- Johann W. Auer, Robert Berent, Thomas Weber, Bernd Eber, Sucharit Bhakdi, Tolga Attila Sagban, Hans-Anton Lehr, Christian Ihling, Ulrich Zähringer, Klaus-Dieter Hungerer, Matthias Blumrich, and Kurt Reifenberg
Circulation 2002;105:e64
[Full text]
- Clinical Investigations and Reports
Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial: To What Extent Is the Reduction in Coronary Events With Pravastatin Explained by On-Study Lipid Levels?
- R. John Simes, Ian C. Marschner, David Hunt, David Colquhoun, David Sullivan, Ralph A.H. Stewart, Wendy Hague, Anthony Keech, Peter Thompson, Harvey White, John Shaw, and Andrew Tonkin
Circulation 2002;105:1162-1169; published online before print as doi:10.1161/hc1002.105136
[Abstract]
[Full text]
- Articles
Effect of 3 Months of Antimicrobial Treatment With
Clarithromycin in Acute Non--Q-Wave Coronary
Syndrome
- Juha Sinisalo, Kimmo Mattila, Ville Valtonen, Olli Anttonen, Jukka Juvonen, John Melin, Helena Vuorinen-Markkola, and Markku S. Nieminen
Circulation published March 11, 2002, doi:10.1161/01.CIR.0000012544.07696.1F
[Abstract]
- Clinical Investigations and Reports
Subgroup Interactions in the Heart and Estrogen/Progestin Replacement Study: Lessons Learned
- Curt D. Furberg, Eric Vittinghoff, Michael Davidson, David M. Herrington, Joel A. Simon, Nanette K. Wenger, and Stephen Hulley
Circulation 2002;105:917-922; published online before print as doi:10.1161/hc0802.104280
[Abstract]
[Full text]
- Clinical Investigations and Reports
Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular Disease: Predictive Role of C-Reactive Protein
- Elisabetta Rossi, Luigi M. Biasucci, Franco Citterio, Simona Pelliccioni, Claudia Monaco, Francesca Ginnetti, Dominick J. Angiolillo, Gianni Grieco, Giovanna Liuzzo, and Attilio Maseri
Circulation 2002;105:800-803; published online before print as doi:10.1161/hc0702.104126
[Abstract]
[Full text]
- Articles
Relationship Between Lipid Levels and Clinical
Outcomes in the Long-Term Intervention With Pravastatin in
Ischemic Disease (LIPID) Trial. To What Extent Is the Reduction in
Coronary Events With Pravastatin Explained by
On-Study Lipid Levels?
- R. John Simes, Ian C. Marschner, David Hunt, David Colquhoun, David Sullivan, Ralph A.H. Stewart, Wendy Hague, Anthony Keech, Peter Thompson, Harvey White, John Shaw, Andrew Tonkin, and on
Behalf of the LIPID Study
Investigators
Circulation published February 18, 2002, doi:10.1161/hc1002.105136
[Abstract]
- Clinical Investigations and Reports
Early and Sustained Survival Benefit Associated With Statin Therapy at the Time of Percutaneous Coronary Intervention
- Albert W. Chan, Deepak L. Bhatt, Derek P. Chew, Martin J. Quinn, David J. Moliterno, Eric J. Topol, and Stephen G. Ellis
Circulation 2002;105:691-696; published online before print as doi:10.1161/hc0602.103586
[Abstract]
[Full text]
- Clinical Investigations and Reports
Department of Veterans Affairs Cooperative Studies Program Clinical Trial Comparing Combined Warfarin and Aspirin With Aspirin Alone in Survivors of Acute Myocardial Infarction: Primary Results of the CHAMP Study
- Louis D. Fiore, Michael D. Ezekowitz, Mary T. Brophy, David Lu, Joseph Sacco, and Peter Peduzzi
Circulation 2002;105:557-563, doi:10.1161/hc0502.103329
[Abstract]
[Full text]
- Articles
Subgroup Interactions in the Heart and
Estrogen/Progestin Replacement Study. Lessons Learned
- Curt D. Furberg, Eric Vittinghoff, Michael Davidson, David M. Herrington, Joel A. Simon, Nanette K. Wenger, and Stephen Hulley
Circulation published January 22, 2002, doi:10.1161/hc0802.104280
[Abstract]
|
|
